Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BA Drugs used in nicotine dependence
N07BA01 Nicotine
D03365 Nicotine (USP) <JP/US>
USP drug classification [BR:br08302]
Anti-Addiction/Substance Abuse Treatment Agents
Smoking Cessation Agents
Nicotine
D03365 Nicotine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
7 Agents not mainly for therapeutic purpose
79 Other agents not mainly for therapeutic purpose
799 Miscellaneous
7990 Miscellaneous
D03365 Nicotine (USP)
Classification of Japanese OTC drugs [BR:br08313]
Stop smoking aid
77 Stop smoking aid
D03365 Nicotine (USP)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Designated second-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Second-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00994 Nicotine
D03365 Nicotine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
DG00994 Nicotine
D03365 Nicotine
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Acetylcholine (nicotinic)
CHRN
D03365 Nicotine (USP) <JP/US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03365
Rx-to-OTC switch list in the USA [br08315.html]
D03365
Rx-to-OTC switch list in Japan [br08314.html]
D03365
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00994 Nicotine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
DG00994 Nicotine
